Boston Scientific (BSX) PT Raised to $132 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst William Plovanic raised the price target on Boston Scientific (NYSE: BSX) to $132.00 (from $131.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
